Results 301 to 310 of about 1,150,712 (337)
Neoadjuvant strategies in locally advanced prostate cancer: progress or premature? [PDF]
Transl Androl UrolFazekas T, Nyirády P, Heidegger I.
europepmc +1 more source
Low Testosterone Level and Mortality Risk in Patients With Prostate Cancer: A Post-Randomization Analysis. [PDF]
Cancer MedFattahi S +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Critical Reviews in Oncology/Hematology, 2005
Prostate carcinoma, with about 190,000 new cases occurring each year (15% of all cancers in men), is the most frequent cancer among men in northern and western Europe. Causes of the disease are essentially unknown, although hormonal factors are involved, and diet may exert an indirect influence; some genes, potentially involved in hereditary prostate ...
S. Bracarda +7 more
openaire +4 more sources
Prostate carcinoma, with about 190,000 new cases occurring each year (15% of all cancers in men), is the most frequent cancer among men in northern and western Europe. Causes of the disease are essentially unknown, although hormonal factors are involved, and diet may exert an indirect influence; some genes, potentially involved in hereditary prostate ...
S. Bracarda +7 more
openaire +4 more sources
Prostatitis and prostate cancer: Implications for prostate cancer screening
Urology, 2004Measurement of serum prostate-specific antigen (PSA) levels has become the most important single clinical test in the screening for prostate cancer. The possibility that prostatic inflammation (even in asymptomatic men) may substantially elevate PSA values is an important clinical problem, especially given the vagaries of prostate cancer ...
D. Robert Siemens +2 more
openaire +3 more sources
Immunotherapy for prostate cancer [PDF]
Current Urology Reports, 2003 Whereas androgen deprivation and chemotherapy have become the cornerstone of therapy for advanced prostate cancer, novel therapies are being developed that may expand upon currently available treatments. The identification of antigens expressed by prostate tissue and/or prostate cancer that are recognized by T cells or antibodies creates opportunities ...
Lawrence Fong, Eric J. Small
openaire +6 more sources
Current Opinion in Oncology, 1997
Prostate cancer accounted for over 41,000 deaths in the United States in 1996. Prostate-specific antigen (PSA) screening is capable of detecting prostate cancer and appears to detect cancers that are both clinically significant as well as organ-confined, and therefore potentially curable. The positive predictive value of PSA value has been increased by
openaire +3 more sources
Prostate cancer accounted for over 41,000 deaths in the United States in 1996. Prostate-specific antigen (PSA) screening is capable of detecting prostate cancer and appears to detect cancers that are both clinically significant as well as organ-confined, and therefore potentially curable. The positive predictive value of PSA value has been increased by
openaire +3 more sources